(Q39672342)

13 September 2017

title

PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells (English)

1 reference

13 September 2017

0 references

Ameera Gaafar Mohamed

2

1 reference

13 September 2017

Ibtehaj Al-Sharif

3

1 reference

13 September 2017

Basem Al-Otaibi

6

1 reference

13 September 2017

Amal Al-Haza'a

7

1 reference

13 September 2017

Ibrahim Al-Jammaz

8

1 reference

13 September 2017

Khaled Al-Hussein

9

1 reference

13 September 2017

Abdelilah Aboussekhra

10

1 reference

13 September 2017

Ensaf M. Al-Hujaily

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20680677

15 June 2024

Khairia M. Youssef

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20680677

15 June 2024

Pulicat S. Manogaran

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20680677

15 June 2024

language of work or name

English

0 references

publication date

1 August 2010

1 reference

full work available at URL

13 September 2017

http://link.springer.com/content/pdf/10.1007/s10549-010-1089-3.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1089-3

http://link.springer.com/article/10.1007/s10549-010-1089-3/fulltext.html

15 June 2024

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1089-3

http://link.springer.com/content/pdf/10.1007/s10549-010-1089-3

15 June 2024

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1089-3

Breast Cancer Research and Treatment

15 June 2024

published in

1 reference

13 September 2017

volume

128

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

97-107

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-010-1089-3

13 September 2017

exact match

0 references

cites work

Trends in breast cancer by race and ethnicity: update 2006.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

Chemosensitization and radiosensitization of tumors by plant polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

Curcumin inhibition of integrin (alpha6beta4)-dependent breast cancer cell motility and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

Curcumin and cancer: an "old-age" disease with an "age-old" solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

Bioavailability of curcumin: problems and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

Synthesis and evaluation of electron-rich curcumin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

Fluorocurcumins as cyclooxygenase-2 inhibitor: molecular docking, pharmacokinetics and tissue distribution in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

New difluoro Knoevenagel condensates of curcumin, their Schiff bases and copper complexes as proteasome inhibitors and apoptosis inducers in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

Synthesis of curcumin analogues as potential antioxidant, cancer chemopreventive agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

Physiologic estrogen receptor alpha signaling in non-tumorigenic human mammary epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

The tumor suppressor p16(INK4a) gene is a regulator of apoptosis induced by ultraviolet light and cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

Survivin, cancer networks and pathway-directed drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

p53 and breast cancer, an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

The role of p53 and pRB in apoptosis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

E2F1-induced apoptosis: turning killers into therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

NF-kappaB in mammary gland development and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

Exploiting our knowledge of NF-kappaB signaling for the treatment of mammary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

Nuclear factor-kappaB in development, prevention, and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

Interleukin-4 and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

Interleukin-10 and the immune response against cancer: a counterpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1089-3

21 January 2018

Biochemical Pharmacology

3

19

19

A Goel

2007

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1089-3

Curcumin prevents tumor-induced T cell apoptosis through Stat-5a-mediated Bcl-2 induction

15 June 2024

5

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1089-3

Biochimica et Biophysica Acta

15 June 2024

27

1471

M43

GP Dotto

2000

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1089-3

Wnt signaling pathway in invasive ductal carcinoma of the breast: relationship between beta-catenin, dishevelled and cyclin D1 expression

15 June 2024

35

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1089-3

Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index

15 June 2024

39

1 reference

https://api.crossref.org/works/10.1007/S10549-010-1089-3

15 June 2024

Identifiers

1 reference

release_oc2tfomg6zfg5fqvt7wv5uqkoa

13 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oc2tfomg6zfg5fqvt7wv5uqkoa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference